Nov 12, 2020 / 03:00PM GMT
Mads Kronborg - Zealand Pharma A/S-Head of IR&Communication
Welcome, and thank you for joining us today to discuss Zealand's Third Quarter 2020 Financial Results. With me today are Zealand's Chief Executive Officer, Emmanuel Dulac; Chief Financial Officer, Matt Dallas; and Chief Medical Officer, Adam Steensberg.
The team will respectively provide business, financial and development highlights from the third quarter of 2020. After the prepared remarks, we will open the call to take your questions. You can find our Q3 2020 interim report and additional supporting information on our website at zealandpharma.com.
As a company headquartered in Denmark, our financials are reported in Danish crowns, also referred to as krone. Key figures may have been converted to U.S. dollars for convenience.
I would like to point out that we will be making forward-looking statements that are subject to risks and uncertainties. These statements are valid only as of today, and the company assumes no obligation to update them except as required by
Q3 2020 Zealand Pharma A/S Earnings Call Transcript
Nov 12, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers